Skip to search.
 STI Down 0.18%

Merck & Co. Inc. (MRK)

-NYSE
56.88 Down 0.96(1.66%) 18 Apr 04:03 SGT
|After Hours : 56.83 Down 0.05 (0.09%) 18 Apr 07:41 SGT
Add to Portfolio
Prev Close:57.84
Open:57.35
Bid:56.83 x 100
Ask:56.99 x 300
1y Target Est:63.83
Beta:0.46
Next Earnings Date:28-Apr-15MRK Earnings announcement
Day's Range:56.57 - 57.36
52wk Range:52.49 - 63.62
Volume:11,663,352
Avg Vol (3m):11,112,800
Market Cap:161.44B
P/E (ttm):13.98
EPS (ttm):4.07
Div & Yield:1.80 (3.10%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MRKDown 1.66%161.44B
GSKDown 0.61%113.76B
NVSDown 0.82%245.76B
PFEDown 0.43%214.76B

Key Statistics

Forward P/E (1 yr):14.97
P/S (ttm):3.89
Ex-Dividend Date:12-Mar-15

Analysts

Annual EPS Est (Dec-15) :3.38
Quarterly EPS Est (Mar-15) :0.74
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):3.37

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infec... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback